CharactHer. ICORG 12-09, V3
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- HER2 Positive Breast Cancer
- TNM Stage II-IV Breast Cancer
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Retrospective
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Only males
Description
Type of Study: Translational This is a pilot retrospective laboratory-based cohort study. Eligible patients will be identified at each one of the participating institutions by a systematic cross-matching of the datasets of Medical Oncology, Pathology and Pharmacy Departments. Patient Population: Coh...
Type of Study: Translational This is a pilot retrospective laboratory-based cohort study. Eligible patients will be identified at each one of the participating institutions by a systematic cross-matching of the datasets of Medical Oncology, Pathology and Pharmacy Departments. Patient Population: Cohort 1: TNM stage II-IV breast cancer patients with highly trastuzumab-sensitive tumours. Cohort 2: (Control group) TNM stage II-IV breast cancer patients with trastuzumab-refractory disease.
Tracking Information
- NCT #
- NCT01722890
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Giuseppe Gullo, Medicine and Surgery St. Vincent's University Hospital